TATAA specializes in cell and gene therapy bioanalytical assays and biomarker profiling for precision medicine through genomics, transcriptomics, and proteomics services. TATAA’s robust molecular analyses allow biopharma researchers to define drug targets, select patient populations, prioritize drug formulations, and prepare IND filings.
Approval enables regulated analysis services for cell and gene therapies. This important milestone for TATAA Biocenter provides customers access to safety testing, accelerating the transition of promising therapies from laboratory research and preclinical testing to clinical applications. TATAA Biocenter announced today that it has been awarded Good Laboratory Practice (GLP) accreditation. The accreditation represents a […]
TATAA Biocenter (the “Company” or “TATAA”), a leading global CRO for high-quality molecular analysis, announced the formation of its Scientific Advisory Board (“SAB”). The SAB will advise the Company and its leadership team on strategic matters, research and development initiatives, and other areas where their expertise is beneficial to the growth of TATAA’s services. The […]
TATAA Biocenter appoints Johanna Nilsson as new Head of Marketing to strengthen scientific communication and client engagement TATAA Biocenter (the “Company” or “TATAA”), a leading global CRO for high-quality molecular analysis, is pleased to announce the appointment of Johanna Nilsson as Head of Marketing. She will in her new role facilitate streamlined communication between TATAA’s […]
TATAA Biocenter, a leading global CRO for high-quality molecular analysis, announced the promotion of Sofia Adolfsson to Head of Bioinformatics and Scientific Officer.
TATAA Biocenter AB announces new leadership team to support long-term ambitions TATAA Biocenter AB (the “Company” or “TATAA”), a leading global CRO for high-quality molecular analysis, today announces a new leadership team to support the Company’s continued growth and long-term ambitions. The new appointments include Mathias Hallin to the role of Chief Executive Officer, Kennet […]
TATAA Biocenter, a leading CRO of molecular analysis services, announces it has become a certified service provider for RealSeq Biosciences, a developer of innovative sequencing solutions for microRNA analysis. This collaboration will bring considerable benefits to scientific researchers by providing access to a comprehensive range of molecular analysis services, including RealSeq Biosciences’ cutting-edge small RNA […]
© Care Equity Capital Management L.P. New York, New York
